TickerFactsScreenerDevelopers

IRADIMED CORP (IRMD) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $1.70M2013: $2.46M2014: $9.45M2015: $19.37M2016: $17.71M2017: $18.21M2018: $28.03M2019: $43.48M2020: $50.07M2021: $62.00M2022: $57.96M2023: $49.76M2024: $52.23M2025: $51.16M$51.16M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$51.16M-2.1%
2024$52.23M+5.0%
2023$49.76M-14.1%
2022$57.96M-6.5%
2021$62.00M+23.8%
2020$50.07M+15.1%
2019$43.48M+55.1%
2018$28.03M+53.9%
2017$18.21M+2.8%
2016$17.71M-8.5%
2015$19.37M+104.9%
2014$9.45M+284.1%
2013$2.46M+45.0%
2012$1.70M—